Skip to main content
Clinical Trials/NCT06016816
NCT06016816
Completed
Not Applicable

The Effect of Bilateral Sphenopalatine Ganglion Block on Postoperative Pain in Patients to be Subject to Septorhinoplasty Surgery

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital1 site in 1 country72 target enrollmentJanuary 9, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anesthesia of Mucous Membrane
Sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Enrollment
72
Locations
1
Primary Endpoint
Numeric Rating Scale
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to examine the effects of bilateral sphenopalatine ganglion block on surgical conditions, hemodynamics, intraoperative and postoperative analgesic use, recovery characteristics, and postoperative pain during septorhinoplasty under general anesthesia. The study was planned as double-blind, randomized, controlled. 72 patients who will undergo septorhinoplasty surgery will be collected. (g power analysis was performed.) Evaluation of the effectiveness of bilateral sphenopalatine ganglion block was planned. Patients will be divided into 2 equal groups (36 patients). After the induction of general anesthesia, one group (Group: 1) will be administered 8mg dexamethasone and 10mg bupivacaine submucosal, the other group (group:2) will be administered 4 cc saline. aspects will be evaluated.

Registry
clinicaltrials.gov
Start Date
January 9, 2024
End Date
February 2, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Hülya Tosun Söner

Principal Investigator

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • patients with an ASA score of I-II and between the ages of 17-45 years, who were to undergo general anesthesia with desflurane, were included in the study.

Exclusion Criteria

  • Patients aged \<17 and \>45 years, patients with liver and/or kidney failure, obese patients (BMI \>30), trauma patients, ASA III-IV patients, patients with bleeding disorders, those using drugs that may affect the coagulation system, patients with cardiomyopathy, cerebrovascular disease, immobility, and malnutrition were excluded from the study.

Outcomes

Primary Outcomes

Numeric Rating Scale

Time Frame: Postoperative 0-2 hours, 2-8 hours,8-24 hours

They will be numbered from 1 to 10. 1 mildest 10 most severe pain

Secondary Outcomes

  • intraoperative remifentanil consumption(intraoperative)
  • Riker Agitation Scale(Immediately after extubation)
  • edema questionnaire(Postoperative 0-2 hours, 2-8 hours,8-24 hours)
  • mean arterial pressure(when you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubation)
  • hematoma questionnaire(Postoperative 0-2 hours, 2-8 hours,8-24 hours)
  • heart rate(when you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubation)
  • vomiting questionnaire(Postoperative 0-2 hours, 2-8 hours,8-24 hours)
  • Oral analgesic use(In the first 24 hours after surgery)

Study Sites (1)

Loading locations...

Similar Trials